Table 3 Comparison between post-Kasai patients and other cholestatic patients before intervention
From: Zinc status in infants and children with cholestatic liver diseases and its effect on growth
Variables | Cholestasis (n = 28) | Post-Kasai (n = 27) | P value |
|---|---|---|---|
MUAC Z-score (median (IQR), [range]) | − 1.5 (2.2), [− 5.8:0.83] | − 1.2 (1.7), [− 5.9:0.92] | > 0.05 |
MUAC percentile (median (IQR), [range]) | 6.5 (44), [0.00:80] | 12 (38), [0.00:82] | > 0.05 |
TSF Z-score (median (IQR), [range]) | − 2.8 (1.2), [− 7.73:− 0.07] | − 2.2 (2.2), [− 7.6:0.2] | > 0.05 |
TSF percentile (median (IQR), [range]) | 0.00 (1), [0.00:47] | 1 (10), [0.00:58] | > 0.05 |
Weight Z-score (median (IQR), [range]) | − 1.5 (1.8), [− 3.9:6.3] | − 0.6 (1.8), [− 5.5:0.9] | > 0.05 |
Weight percentile (median (IQR), [range]) | 4 (21), [0.00:97] | 22.5 (41.7), [− 2.7:81] | > 0.05 |
Height (length) Z-score (median (IQR), [range]) | − 1.8 (1.7), [− 4.8:2.4] | − 0.9 (2.8), [− 3.6:41] | > 0.05 |
Height (length) percentile (median (IQR), [range]) | 3 (11), [0.00:99] | 14.5 (44.5), [− 0.2:92] | > 0.05 |
Serum Zn (mean ± SD) μg/l | 1222 ± 512 | 1282 ± 610 | > 0.05 |
IGF-1 (median (IQR), [range]) ng/ml | 46 (81), [10:550] | 57 (369), [18:780] | > 0.05 |